Home › Funds › Balyasny Asset Management › MXCT
Balyasny Asset Management position in MXCT
MAXCYTE INC · Health Care
Latest position (Q2 2026)13.55K sh
Reported value held$16.66K
Portfolio Weight0.00%
First reportedQ2 2026
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 13.55K | $16.66K | New |
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Citadel Advisors 955.72K sh · $1.18M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026